STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma
Authors:
- Ana Paula MorelliAMAna Paula Morelli
- Tharcísio Citrângulo TortelliTTTharcísio Citrângulo Tortelli
- Mariana Camargo Silva ManciniMMMariana Camargo Silva Mancini
- Luiz Guilherme Salvino SilvaLSLuiz Guilherme Salvino Silva
- Matheus Brandemarte SeverinoMSMatheus Brandemarte Severino
- Luis Gustavo Saboia PonteLPLuis Gustavo Saboia Ponte
- Daniel Francisco Guimarães dos SantosDSDaniel Francisco Guimarães dos Santos
Open Access
- 17 September 2021
- Vol. 23 (10) , 1048-1058
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/00311-1, 2015/22814-5, 2018/14818-9, 2019/00607‐9, 2019/25582-9, 2020/09527-5)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (447553/2014-3)
This publication has 59 references indexed in Scilit:
- Genome engineering using the CRISPR-Cas9 systemNature Protocols, 2013
- Lamin A/C Depletion Enhances DNA Damage-Induced Stalled Replication Fork ArrestMolecular and Cellular Biology, 2013
- PIG3: A novel link between oxidative stress and DNA damage response in cancerCancer Letters, 2012
- Primer-BLAST: A tool to design target-specific primers for polymerase chain reactionBMC Bioinformatics, 2012
- Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cellsCancer Letters, 2012
- Molecular mechanisms of cisplatin resistanceOncogene, 2011
- Quantitative Proteomic and Interaction Network Analysis of Cisplatin Resistance in HeLa CellsPLOS ONE, 2011
- The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene functionNucleic Acids Research, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008